The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Matrix metalloproteinases: Fold and function of their catalytic domains
Open accessAbstract
Matrix metalloproteinases (MMPs) are zinc-dependent protein and peptide hydrolases. They have been almost exclusively studied in vertebrates and 23 paralogs are present in humans. They are widely involved in metabolism regulation through both extensive protein degradation and selective peptide-bond hydrolysis. If MMPs are not subjected to exquisite spatial and temporal control, they become destructive, which can lead to pathologies such as arthritis, inflammation, and cancer. The main therapeutic strategy to combat the dysregulation of MMPs is the design of drugs to target their catalytic domains, for which purpose detailed structural knowledge is essential. The catalytic domains of 13 MMPs have been structurally analyzed so far and they belong to the "metzincin" clan of metalloendopeptidases. These compact, spherical, approximately 165-residue molecules are divided by a shallow substrate-binding crevice into an upper and a lower sub-domain. The molecules have an extended zinc-binding motif, HEXXHXXGXXH, which contains three zinc-binding histidines and a glutamate that acts as a general base/acid during catalysis. In addition, a conserved methionine lying within a "Met-turn" provides a hydrophobic base for the zinc-binding site. Further earmarks of MMPs are three alpha-helices and a five-stranded beta-sheet, as well as at least two calcium sites and a second zinc site with structural functions. Most MMPs are secreted as inactive zymogens with an N-terminal approximately 80-residue pro-domain, which folds into a three-helix globular domain and inhibits the catalytic zinc through a cysteine imbedded in a conserved motif, PRCGXPD. Removal of the pro-domain enables access of a catalytic solvent molecule and substrate molecules to the active-site cleft, which harbors a hydrophobic S(1')-pocket as main determinant of specificity. Together with the catalytic zinc ion, this pocket has been targeted since the onset of drug development against MMPs. However, the inability of first- and second-generation inhibitors to distinguish between different MMPs led to failures in clinical trials. More recent approaches have produced highly specific inhibitors to tackle selected MMPs, thus anticipating the development of more successful drugs in the near future. Further strategies should include the detailed structural characterization of the remaining ten MMPs to assist in achieving higher drug selectivity. In this review, we discuss the general architecture of MMP catalytic domains and its implication in function, zymogenic activation, and drug design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
On the size of the active site in proteases. I. Papain
Schechter, I., & Berger, A. (1967) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(67)80055-x · Cited by 5,204
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
Advanced Organic Chemistry: Reactions, Mechanisms, and Structure
March, J. (1977) · Andalas University Repository (Andalas University) · Cited by 4,022
Nagase, H., & Woessner, J. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21491 · Cited by 3,912
Matrix Metalloproteinases: A Review
Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., & Engler, J. A. (1993) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411930040020401 · Cited by 2,970
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Handbook of Proteolytic Enzymes
(2004) · Elsevier eBooks · doi:10.1016/c2009-0-03628-9 · Cited by 2,616
Zinc coordination, function, and structure of zinc enzymes and other proteins
Vallee, B. L., & Auld, D. S. (1990) · Biochemistry · doi:10.1021/bi00476a001 · Cited by 1,777
Van Wart, H. E., & Birkedal-Hansen, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5578 · Cited by 1,475
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
COLLAGENOLYTIC ACTIVITY IN AMPHIBIAN TISSUES: A TISSUE CULTURE ASSAY
Gross, J., & Lapiere, C. M. (1962) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.48.6.1014 · Cited by 1,310
SETOR: Hardware-lighted three-dimensional solid model representations of macromolecules
Evans, S. V. (1993) · Journal of Molecular Graphics · doi:10.1016/0263-7855(93)87009-t · Cited by 1,279
EDWARDS, D., HANDSLEY, M., & PENNINGTON, C. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.001 · Cited by 1,161
Activation mechanisms of matrix metalloproteinases.
Nagase, H. (1997) · PubMed · Cited by 1,119
Matrix metalloproteinases: a tail of a frog that became a prince
Brinckerhoff, C. E., & Matrisian, L. M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm763 · Cited by 1,105
Human and mouse proteases: a comparative genomic approach
Puente, X. S., Sánchez, L. M., Overall, C. M., & López-Otín, C. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1111 · Cited by 943
Emerging roles of proteases in tumour suppression
López-Otín, C., & Matrisian, L. M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2228 · Cited by 802
Progress in matrix metalloproteinase research
MURPHY, G., & NAGASE, H. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.05.002 · Cited by 759
Bode, W., Gomis-Rüth, F.-X., & Stöckler, W. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80312-i · Cited by 757
Self-citationStöcker, W., Grams, F., Reinemer, P., Bode, W., Baumann, U., Gomis‐Rüth, F., & Mckay, D. B. (1995) · Protein Science · doi:10.1002/pro.5560040502 · Cited by 726
Self-citationSpringman, E. B., Angleton, E. L., Birkedal-Hansen, H., & Van Wart, H. E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.364 · Cited by 713
Hayakawa, T., Yamashita, K., Tanzawa, K., Uchijima, E., & Iwata, K. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80015-9 · Cited by 695
Structural basis of the action of thermolysin and related zinc peptidases
Matthews, B. W. (1988) · Accounts of Chemical Research · doi:10.1021/ar00153a003 · Cited by 687
The Nucleobase‐Cation‐Symport‐1 Family of Membrane Transport Proteins
Weyand, S., Ma, P., Saidijam, M., Baldwin, J., Beckstein, O., Jackson, S., Suzuki, S., Patching, S. G., Shimamura, T., Sansom, M. S., et al. (2004) · Handbook of Metalloproteins · doi:10.1002/0470028637.met268 · Cited by 619
Structure of Human Pro-Matrix Metalloproteinase-2: Activation Mechanism Revealed
Morgunova, E., Tuuttila, A., Bergmann, U., Isupov, M., Lindqvist, Y., Schneider, G., & Tryggvason, K. (1999) · Science · doi:10.1126/science.284.5420.1667 · Cited by 540
The ADAMs: signalling scissors in the tumour microenvironment
Murphy, G. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2459 · Cited by 451
Mechanisms for pro matrix metalloproteinase activation
MURPHY, G., STANTON, H., COWELL, S., BUTLER, G., KNÄUPER, V., ATKINSON, S., & GAVRILOVIC, J. (1999) · APMIS · doi:10.1111/j.1699-0463.1999.tb01524.x · Cited by 441
Active-site zinc ligands and activated H2O of zinc enzymes.
Vallee, B. L., & Auld, D. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.220 · Cited by 437
In search of partners: linking extracellular proteases to substrates
Overall, C. M., & Blobel, C. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2120 · Cited by 349
Towards third generation matrix metalloproteinase inhibitors for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603043 · Cited by 340
Structural aspects of the metzincin clan of metalloendopeptidases
Gomis-Rüth, F. X. (2003) · Molecular Biotechnology · doi:10.1385/mb:24:2:157 · Cited by 340
Self-citationBecker, J. W., Marcy, A. I., Rokosz, L. L., Axel, M. G., Burbaum, J. J., Fitzgerald, P. M. D., Cameron, P. M., Esser, C. K., Hagmann, W. K., Hermes, J. D., et al. (1995) · Protein Science · doi:10.1002/pro.5560041002 · Cited by 293
Hangauer, D. G., Monzingo, A. F., & Matthews, B. W. (1984) · Biochemistry · doi:10.1021/bi00319a011 · Cited by 247
Catalytic Domain Architecture of Metzincin Metalloproteases
Gomis-Rüth, F. X. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800069200 · Cited by 244
Self-citationStructural Basis for the Highly Selective Inhibition of MMP-13
Engel, C. K., Pirard, B., Schimanski, S., Kirsch, R., Habermann, J., Klingler, O., Schlotte, V., Weithmann, K. U., & Wendt, K. U. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.11.014 · Cited by 228
Rao, B. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382115 · Cited by 221
Morgunova, E., Tuuttila, A., Bergmann, U., & Tryggvason, K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102185399 · Cited by 219
Uría, J. A., & López-Otín, C. (2000) · PubMed · Cited by 206
Crystal structures of MMPs in complex with physiological and pharmacological inhibitors
Maskos, K. (2005) · Biochimie · doi:10.1016/j.biochi.2004.11.019 · Cited by 200
Processing, shedding, and endocytosis of membrane type 1‐matrix metalloproteinase (MT1‐MMP)
Osenkowski, P., Toth, M., & Fridman, R. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20064 · Cited by 187
TIMP-2: an endogenous inhibitor of angiogenesis
Stetler-Stevenson, W. G., & Seo, D.-W. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.01.007 · Cited by 180
The Degradome database: mammalian proteases and diseases of proteolysis
Quesada, V., Ordonez, G. R., Sanchez, L. M., Puente, X. S., & Lopez-Otin, C. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn570 · Cited by 172
Development of Selective Inhibitors and Substrate of Matrix Metalloproteinase-12
Devel, L., Rogakos, V., David, A., Makaritis, A., Beau, F., Cuniasse, P., Yiotakis, A., & Dive, V. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600222200 · Cited by 171
Grams, F., Crimmin, M., Hinnes, L., Huxley, P., Pieper, M., Tschesche, H., & Bode, W. (1995) · Biochemistry · doi:10.1021/bi00043a007 · Cited by 168
Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase
Elkins, P. A., Ho, Y. S., Smith, W. W., Janson, C. A., D'Alessio, K. J., McQueney, M. S., Cummings, M. D., & Romanic, A. M. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902007849 · Cited by 158
Monzingo, A. F., & Matthews, B. W. (1984) · Biochemistry · doi:10.1021/bi00319a010 · Cited by 156
Crystal Structures of Recombinant 19-kDa Human Fibroblast Collagenase Complexed to Itself
Lovejoy, B., Hassell, A. M., Luther, M., Weigl, D., & Jordan, S. R. (1994) · Biochemistry · doi:10.1021/bi00193a006 · Cited by 156
Puerta, D. T., Lewis, J. A., & Cohen, S. M. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0485513 · Cited by 148
Structure and Mechanism of Metallocarboxypeptidases
Gomis‐Rüth, F. X. (2008) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230802376375 · Cited by 141
Self-citationStructural implications for the role of the N terminus in the ‘superactivation’ of collagenases
Reinemer, P., Grams, F., Huber, R., Kleine, T., Schnierer, S., Piper, M., Tschesche, H., & Bode, W. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80370-6 · Cited by 135
Regulation of Human ADAM 12 Protease by the Prodomain
Loechel, F., Overgaard, M. T., Oxvig, C., Albrechtsen, R., & Wewer, U. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13427 · Cited by 131
Activation of snake venom metalloproteinases by a cysteine switch‐like mechanism
Grams, F., Huber, R., Kress, L. F., Moroder, L., & Bode, W. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80443-x · Cited by 124
Structural Basis of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases
Maskos, K., & Bode, W. (2003) · Molecular Biotechnology · doi:10.1385/mb:25:3:241 · Cited by 123
X-ray Structure of Human proMMP-1
Jozic, D., Bourenkov, G. P., Lim, N. H., Visse, R., Nagase, H., Bode, W., & Maskos, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411084200 · Cited by 119
Phosphinic peptides as zinc metalloproteinase inhibitors
Dive, V., Georgiadis, D., Matziari, M., Makaritis, A., Beau, F., Cuniasse, P., & Yiotakis, A. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4050-y · Cited by 111
Snapshots of the Reaction Mechanism of Matrix Metalloproteinases
Bertini, I., Calderone, V., Fragai, M., Luchinat, C., Maletta, M., & Yeo, K. J. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200603100 · Cited by 109
Catalytic Mechanism of Matrix Metalloproteinases: Two-Layered ONIOM Study
Pelmenschikov, V., & Siegbahn, P. E. M. (2002) · Inorganic Chemistry · doi:10.1021/ic0255656 · Cited by 105
Kikuchi, K., Kadono, T., Furue, M., & Tamaki, K. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12286457 · Cited by 105
Mosca, R., & Schneider, T. R. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn197 · Cited by 100
Pochetti, G., Montanari, R., Gege, C., Chevrier, C., Taveras, A. G., & Mazza, F. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801166j · Cited by 82
Betz, M., Huxley, P., Davies, S. J., Mushtaq, Y., Pieper, M. P., Tschesche, H., Bode, W., & Gomis‐Rüth, F. X. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00356.x · Cited by 81
Self-citationTallant, C., García-Castellanos, R., Seco, J., Baumann, U., & Gomis‐Rüth, F. X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600907200 · Cited by 78
Self-citationJohnson, L. L., Pavlovsky, A. G., Johnson, A. R., Janowicz, J. A., Man, C.-F., Ortwine, D. F., Purchase, C. F., White, A. D., & HUPE, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11026 · Cited by 76
Matrix metalloproteinase inhibitors as anticancer agents
Konstantinopoulos, P. A., Karamouzis, M. V., Papatsoris, A., & Papavassiliou, A. G. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.11.007 · Cited by 74
Overall, C. M. (2003) · Humana Press eBooks · doi:10.1385/1-59259-046-2:079 · Cited by 71
Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors
Callier‐Dublanchet, A., Ducrot, P., Andrianjara, C. R., O’Gara, M., Morales, R., Compère, D., Denis, A., Blais, S., Cluzeau, P., Courté, K., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.079 · Cited by 68
Matrix Metalloproteinase Inhibitors in Cancer Therapy
Clendeninn, N. J., & Appelt, K. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-011-7 · Cited by 66
Wetmore, D. R., & Hardman, K. D. (1996) · Biochemistry · doi:10.1021/bi9530752 · Cited by 54
Hodgson, J. (1995) · Nature Biotechnology · doi:10.1038/nbt0695-554 · Cited by 49
Butler, G. S., Tam, E. M., & Overall, C. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312727200 · Cited by 48
Elucidating the Function of Non catalytic Domains of Collagenases and Aggrecanases
Nagase, H., & Fushimi, K. (2008) · Connective Tissue Research · doi:10.1080/03008200802151698 · Cited by 45
Structural Basis for Potent Slow Binding Inhibition of Human Matrix Metalloproteinase-2 (MMP-2)
Rosenblum, G., Meroueh, S. O., Kleifeld, O., Brown, S., Singson, S. P., Fridman, R. A., Mobashery, S., & Sagi, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301139200 · Cited by 42
Design, Synthesis, and Evaluation of a Mechanism-Based Inhibitor for Gelatinase A
Ikejiri, M., Bernardo, M. M., Meroueh, S. O., Brown, S., Chang, M., Fridman, R. A., & Mobashery, S. (2005) · The Journal of Organic Chemistry · doi:10.1021/jo050339+ · Cited by 41
Metal and pH Dependence of Heptapeptide Catalysis by Human Matrilysin
Cha, J., Pedersen, M. V., & Auld, D. S. (1996) · Biochemistry · doi:10.1021/bi962085f · Cited by 41
Solomon, A., Akabayov, B., Frenkel, A. I., Milla, M. E., & Sagi, I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700066104 · Cited by 41
Synthetic active site-directed inhibitors of metzincins: Achievement and perspectives
Yiotakis, A., & Dive, V. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.06.001 · Cited by 39
Catalytic mechanisms for metallopeptidases
Auld, D. S. (2004) · Elsevier eBooks · doi:10.1016/b978-0-12-079611-3.50076-8 · Cited by 37
Nagase, H. (2001) · doi:10.1007/978-1-59259-011-7_2 · Cited by 36
The TACE Zymogen: Re-Examining the Role of the Cysteine Switch
Milla, M. E., Gil, P. G., & Leonard, J. D. (2006) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:44:3:342 · Cited by 35
Matrix Metalloproteinase Inhibitors in Cancer Therapy
Clendeninn, N. J., & Appelt, K. (2000) · Humana Press eBooks · doi:10.1385/159259011x · Cited by 31
How tadpoles lose their tails: path to discovery of the first matrix metalloproteinase
Gross, J. (2004) · Matrix Biology · doi:10.1016/j.matbio.2004.01.003 · Cited by 24
Chemistry-based Design of Inhibitors for Carboxypeptidase A
Kim, D. H. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387908 · Cited by 16
Tadpole collagenase, the single parent of such a large family
Lapière, C. M. (2004) · Biochimie · doi:10.1016/j.biochi.2004.09.030 · Cited by 10
Cited by
Role of Matrix Metalloproteinases in Angiogenesis and Cancer
Quintero-Fabián, S., Arreola, R., Becerril-Villanueva, E., Torres-Romero, J. C., Arana-Argáez, V., Lara-Riegos, J., Ramírez-Camacho, M. A., & Alvarez-Sánchez, M. E. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01370 · Cited by 1,036
Limitations in bonding to dentin and experimental strategies to prevent bond degradation
Liu, Y., Tjäderhane, L., Breschi, L., Mazzoni, A., Li, N., Mao, J., Pashley, D. H., & Tay, F. R. (2011) · Journal of Dental Research · doi:10.1177/0022034510391799 · Cited by 665
Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes
Winer, A., Adams, S., & Mignatti, P. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0646 · Cited by 651
Structure and Function of Human Matrix Metalloproteinases
Laronha, H., & Caldeira, J. (2020) · Cells · doi:10.3390/cells9051076 · Cited by 609
Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview
Mondal, S., Adhikari, N., Banerjee, S., Amin, S. A., & Jha, T. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112260 · Cited by 556
Metadata
- Authors
- Tallant, C., Marrero, A., & Gomis-Rüth, F. X.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 1803
- Issue
- 1
- Pages
- 20-28
- ISSN
- 0167-4889 (ISSN-L)
- OpenAlex
- W2136244824
- Cited by
- 463
- References
- 84
- FWCI
- 7.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.